Skip to main content Help with accessibility Skip to main navigation

FILGOTINIB tablets (Jyseleca®▼) for treating moderately to severely active ulcerative colitis

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 23 - Jun - 2022
Body System:
Red
FILGOTINIB tablets (Jyseleca®▼) for treating moderately to severely active ulcerative colitis

The Pan Mersey Area Prescribing Committee recommends the prescribing of FILGOTINIB tablets (Jyseleca®▼), by specialists only, for treating moderately to severely active ulcerative colitis in accordance with NICE TA792.

NHS Cheshire and Merseyside APPROVED